Results 151 to 160 of about 579,543 (207)

Comparative validation of low-density lipoprotein cholesterol estimation formulas in older Georgian adults. [PDF]

Pract Lab Med
Nino G, Lizi M, Nino K.
europepmc   +1 more source

Impact of low-density lipoprotein cholesterol-lowering therapy on intermediate stenosis in non-culprit vessels of acute coronary syndrome. [PDF]

BMC Cardiovasc Disord
Kakehi K, Ueno M, Kayama M, Yamada N, Onishi K, Sugimoto K, Funauchi Y, Kawamura T, Fujita K, Matsuzoe H, Matsumura K, Nakazawa G.   +11 more
europepmc   +1 more source

Effects of Tirzepatide on Low-Density Lipoprotein Cholesterol Levels in Adults: A Systematic Review. [PDF]

Cureus
Hong I, Hidalgo Ramos RA, Dufner Krieger S, Secades D, Ortiz M, Moya Porras LF, Piedra Pacheco AL, Esquivel JE.   +7 more
europepmc   +1 more source

A dose-response relationship between low-density lipoprotein cholesterol levels within the normal range and the incidence of diabetes mellitus: a retrospective cohort study. [PDF]

Front Endocrinol (Lausanne)
Tian Y, Tong J, Xue Z, Lou X, Guo R, Zhao W.   +5 more
europepmc   +1 more source

Harmonisation of Low-Density Lipoprotein Cholesterol Results Obtained with Different Direct Methods: A Study Based on an External Quality Assessment Program. [PDF]

J Clin Med
Ćwiklińska A, Fijałkowska A.
europepmc   +1 more source

Correction to: Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events. [PDF]

Eur Heart J
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Electronegative low-density lipoprotein

Current Opinion in Lipidology, 2004
The occurrence in blood of an electronegatively charged LDL was described in 1988. During the 1990s reports studying electronegative LDL (LDL(-)) were scant and its atherogenic role controversial. Nevertheless, recent reports have provided new evidence on a putative atherogenic role of LDL(-).
José Luis, Sánchez-Quesada, Sonia, Benítez, Jordi, Ordóñez-Llanos   +2 more
openaire   +2 more sources

Low-density lipoprotein heterogeneity

Baillière's Clinical Endocrinology and Metabolism, 1995
As a key feature of the ALP, a raised level of small, dense LDL forms part of what is potentially the most common collection of lipoprotein abnormalities to influence the risk of CHD in the general population. The consistency of the association between a prevalence of small, dense LDL and increased risk of CHD is impressive, though the practical ...
openaire   +2 more sources

Circulating low density lipoprotein (LDL)

Hormone Molecular Biology and Clinical Investigation, 2018
Abstract Low-density lipoprotein (LDL) particles are known as atherogenic agents in coronary artery diseases. They modify to other electronegative forms and may be the subject for improvement of inflammatory events in vessel subendothelial spaces. The circulating LDL value is associated with the plasma PCSK-9 level. They internalize into
Mohsen, Khosravi, Reza, Hosseini-Fard, Mohammad, Najafi   +2 more
openaire   +2 more sources

Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol

Clinical Laboratory, 2017
Malondialdehyde low-density lipoprotein (MDA-LDL) is a major form of oxidized LDL and considered to be more atherogenic than LDL. Information on major determinants of MDA-LDL and their association in subjects who are not under treatment for diabetes mellitus and dyslipidemia is limited.This study included 778 Japanese subjects who were not taking ...
Kengo, Moriyama, Eiko, Takahashi
openaire   +2 more sources